Live Breaking News & Updates on Safety Results

Stay updated with breaking news from Safety results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October

Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic RetinopathyFARMINGTON HILLS, Mich., Oct. 06, 2023 (GLOBE NEWSWIRE) Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced presentations featuring results from the ZETA-1 Phase 2 Trial of APX3330 at the 23rd Euretina Congress to take plac ....

United States , New York , Noord Holland , Veeral Sheth , Corey Davis , Ocuphire Pharma , Rick Rodgers , Viatris Inc , Amsterdam Convention Center , Ocuphire Pharma Inc , Retina Society Scientific Meeting , Drug Administration , Euretina Congress , Presentations Will Feature Data From , Annual Retina Society Scientific Meeting , Daily Treatment , Safety Results , Paper Session , Tolerability Results , Intercontinental New York , Non Proliferative Diabetic Retinopathy , Proliferative Diabetic Retinopathy , Sci Advisors , Diabetic Retinopathy , Ocuphire Pharma , Efractive Eye Disorders ,

U.S. Food and Drug Administration Approves BioMarin's ROCTAVIAN™ (valoctocogene roxaparvovec-rvox), the First and Only Gene Therapy for Adults with Severe…

U.S. Food and Drug Administration Approves BioMarin's ROCTAVIAN™ (valoctocogene roxaparvovec-rvox), the First and Only Gene Therapy for Adults with Severe…
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Single Dose Treatment Available , Severe Hemophilia , Safety Results , Longest Phase , Gene Therapy , Patients Continued ,

Ocuphire Presents APX3330 ZETA-1 Clinical Data in Late-Breaker Session at the American Diabetes Association's Annual Conference

Ocuphire Presents APX3330 ZETA-1 Clinical Data in Late-Breaker Session at the American Diabetes Association's Annual Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Victorh Gonzalez , Corey Davis , Rick Rodgers , Ocuphire Pharma , Bret Shapiro , Viatris Inc , Ocuphire Pharma Inc , Scientific Sessions Of The American Diabetes Association , Daily Treatment , Safety Results , Diabetic Retinopathy , Scientific Sessions , American Diabetes Association , Interim Chief Executive , Private Securities Litigation Reform Act , Lifesci Advisors ,